The IMA Group Continues to Expand Evaluation Services Senior Leadership Team
Move highlights division's growth; brings on noted industry experts Matt High and Elijah MarentetteTARRYTOWN, NY / ACCESSWIRE / June 25,...
Disability
Enlyte Launches Bundled Solution for Auto Bodily Injury Cost Containment
PrecisionDirect allows auto carriers to improve payment accuracy for provider services SAN DIEGO, June 20, 2024 /PRNewswire/ -- During claims settlements...
Tonix Pharmaceuticals Presented Data Comparing Real-World Treatment of Migraine with Industry Guidelines for Non-Oral Products at the Annual Scientific Meeting of the American Headache Society (AHS)
Gap in non-oral prescriptions relative to AHS guidelines represents an opportunity to increase awareness of Tonix’s two FDA-approved non-oral treatments...
Annexon To Present Pivotal Phase 3 Data On Early And Durable Benefits With First-In-Class C1q Blocking Antibody ANX005 In Guillain-Barré Syndrome At 2024 PNS Annual Meeting
Single Infusion of ANX005 Demonstrated Significant Improvements Across Multiple Functional and Prognostic Measures That Expedited Recovery in GBS Patients ANX005...
Intra-Cellular Therapies Announces Positive Topline Results in Second Phase 3 Trial Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder
In Study 502, lumateperone 42 mg achieved statistically significant and clinically meaningful results in both the primary and the key...
Taysha Gene Therapies Announces Positive Clinical Data Across Adult and Pediatric Patients from Low Dose Cohort in Ongoing REVEAL Phase 1/2 Trials Evaluating TSHA-102 in Rett Syndrome
Durable improvements across consistent clinical domains in both adult and pediatric patients, including motor skills, communication/socialization, autonomic function, seizures, and...
Guardian and Wellthy launch new partnership to support working caregivers and inspire well-being®
Available to members in need of care themselves or when supporting others, Guardian becomes the first insurance carrier to include...
Veru to Present at the American Diabetes Association’s 84th Scientific Sessions
MIAMI, FL, June 10, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on...
The European Patent Office announces that a Tunisian team has been selected as a finalist for the Young Inventors Prize 2024
MUNICH, June 6, 2024 /PRNewswire/ -- According to the World Health Organization (WHO), at least 80 million people (or 1%...
Augmental’s Tongue-Based Trackpad, the MouthPad^, Having A Big Impact on the Lives of First Customers
Augmental Expanding its Early Access Program Beginning Today, Adding New Head-Tracking Feature SAN FRANCISCO, June 6, 2024 /PRNewswire/ -- MIT...
Large Clinical Study Finds Home-based Virtual Reality Treatment of Chronic Low Back Pain Clinically Effective Across Key Socio-demographics Factors
Analysis of a randomized, placebo-controlled study of 1,000+ participants indicates socio-demographics are not a factor impacting clinically meaningful reductions in...
Osteal Therapeutics Closes $50M Series D Financing to Support Approval and Commercial Launch of Lead Candidate
Financing led by Zimmer Biomet with participation from existing investors Johnson & Johnson Innovation – JJDC, Inc., Gideon Strategic Partners,...
CirrusMD Completes National Roll-out of VA Health Chat, Providing Care Access for over 6.8 Million Veterans
VA Health Chat is now available to Veterans in all 18 VISNs across the U.S.DENVER, June 05, 2024 (GLOBE NEWSWIRE)...
Cohere Health, Medical Mutual, and Rhyme Partner on Utilization Management Transformation
Intelligent prior authorization enables faster access to care and higher quality outcomes for members while enhancing provider experience and improving...
Nalu PNS System Achieves Significant and Durable Pain Reduction, Meeting the Primary Endpoint of the COMFORT RCT Study
CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical Inc. (“Nalu”) revealed significant findings from a landmark clinical trial evaluating the Nalu Peripheral Nerve Stimulation...
TG Therapeutics Announces Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting
NEW YORK, May 31, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced presentations highlighting study designs for...
Theralase(R) Release’s 1Q2024 Financial Statements
TORONTO, ON / ACCESSWIRE / May 30, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ")...
AIDPH Provides Written Testimony on Senate Committee Dental Crisis Hearing
Testimony Offers Policy Solutions for Veterans, People with Disabilities, LGBTQIA+ People, and Rural CommunitiesWASHINGTON, DC / ACCESSWIRE / May 29,...
Assured Allies Announces a Multi-Year Partnership to Support CalPERS Long-Term Care Policyholders in Maintaining Their Independence
Assured Allies will provide the AgeAssured program to over 45,000 CalPERS policyholders for a period of at least 5 yearsAgeAssured...
IRLAB has Administered the First Dose in a Phase I Clinical Trial with the Drug Candidate IRL757
GOTHENBURG, SWEDEN / ACCESSWIRE / May 22, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, May 22, 2024 - IRLAB Therapeutics...